Importing Peptide APIs to the US: Compliance Checklist

Importing peptide Active Pharmaceutical Ingredients (APIs) into the United States involves navigating FDA requirements, customs regulations, and documentation standards that can trip up even experienced procurement professionals. This checklist covers the essential compliance requirements for lawful peptide API importation.

Understanding the Regulatory Framework

The FDA regulates the importation of pharmaceutical ingredients under the Federal Food, Drug, and Cosmetic Act. Peptide APIs intended for use in drug compounding must meet specific requirements depending on the intended use and the importing entity's regulatory status.

Who Can Import Peptide APIs?

• FDA-registered 503B outsourcing facilities: Can import bulk APIs for use in compounded preparations
• Licensed compounding pharmacies (503A): Can import APIs through registered importers if components meet USP/NF monograph standards
• Research institutions: Can import research-grade materials with appropriate documentation
• Drug manufacturers: Can import under their IND, NDA, or ANDA frameworks

Pre-Import Compliance Checklist

Supplier Qualification

• Verify the foreign manufacturer is FDA-registered (search the FDA Establishment Registration database)
• Obtain the manufacturer's Drug Master File (DMF) reference number if available
• Review the manufacturer's most recent regulatory inspection history
• Obtain and verify GMP certificates from recognized authorities
• Request stability data for the specific peptide being imported

Documentation Package

• Certificate of Analysis (COA) from an independent, accredited laboratory
• Certificate of Origin
• Material Safety Data Sheet (MSDS/SDS)
• GMP certificate from a recognized regulatory authority
• Full characterization data (HPLC, LC-MS, amino acid analysis, endotoxin testing)
• Shipping and handling specifications (cold chain requirements, packaging standards)

Customs and Entry Requirements

• Correct Harmonized Tariff Schedule (HTS) code classification
• FDA Prior Notice submission (if applicable)
• Customs bond (continuous or single-entry)
• Commercial invoice with accurate product description, quantity, and value
• Packing list
• Bill of lading or airway bill

Common Import Pitfalls

FDA Import Alerts

The FDA maintains import alerts that can result in automatic detention of shipments from specific manufacturers, countries, or product types. Check the FDA Import Alert database before finalizing supplier selection. Import Alert 66-40, for example, covers drugs from firms that have not been inspected and found to comply with cGMP requirements.

Cold Chain Failures

Many peptides require cold chain transport (2-8°C). Shipments that arrive with temperature excursion documentation or without temperature monitoring data may need to be rejected. Specify cold chain requirements in purchase orders and verify compliance on receipt.

Labeling Requirements

Imported APIs must be properly labeled with the correct chemical name, lot/batch number, quantity, storage conditions, manufacturer information, and expiry date. Missing or incorrect labeling can result in detention at the border.

Post-Import Requirements

• Incoming quality inspection against the COA specifications
• Independent identity testing to confirm the material matches the COA
• Proper storage under specified conditions with temperature monitoring
• Documentation retention for the regulatory retention period (varies by entity type)
• Adverse event reporting if quality issues are identified after use

For the full regulatory compliance framework, see our Peptide Regulatory Compliance Guide.